GlassScriptPhysician profile
Sandra B Lopez
NPI 1770676884
$1,725.87
in general payments reported to CMS, 2019-2025
19 companies · $97.25 in 2025
The $97.25 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $331 · 2022: $444 · 2023: $344 · 2024: $510 · 2025: $97.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $368.21 | 2023-2024 | Sotyktu |
| Abbvie INC. | $231.91 | 2021-2025 | |
| Galderma Laboratories, L.P. | $223.88 | 2021-2024 | |
| Janssen Biotech, INC. | $185.94 | 2022-2023 | Stelara, Simponi, Simponi Aria |
| Sun Pharmaceutical Industries INC. | $125.08 | 2022-2025 | |
| Viiv Healthcare Company | $110.94 | 2021-2024 | Dovato |
| Alnylam Pharmaceuticals INC. | $93.93 | 2024 | Amvuttra |
| Amgen INC. | $73.82 | 2021-2024 | Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.62 | 2022-2024 | Spevigo |
| Novartis Pharmaceuticals Corporation | $50.97 | 2022-2025 | |
| Genentech USA, INC. | $42.13 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $29.06 | 2023-2025 | Valchlor |
| Abbott Laboratories | $24.37 | 2021 | |
| Dermavant Sciences, INC. | $22.88 | 2024 | Vtama |
| Regeneron Healthcare Solutions, INC. | $21.73 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $20.88 | 2024 | Rhodoled Xl, Ameluz, Xepi |
| Zimmer Biomet Holdings, INC. | $19.23 | 2021 | |
| Allergan, INC. | $13.28 | 2022 | |
| Organon LLC | $1.01 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.